Page 86 of 90 for 'Pharmaceutical' in Pharmaceutical

Filters

Result types

Showing 851 - 860 of 896 for "Pharmaceutical" with applied filters

Filters:

News & Analysis

An overview of post-grant opposition procedure in Brazil

09 August 2022 by Licks Attorneys

IP practitioners from Licks Attorneys explain how to challenge the Brazilian Patent Office's decision to grant a patent

News & Analysis

MIP Top 250 Women in IP interview: Q&A with Christine Kanz

04 January 2022 by Managing IP

Christine Kanz of Hoyng Rokh Monegier in Germany talks about her career in IP law, what she learned from a recent client matter, and life outside work

News & Analysis

EPO data: Foodstuffs patent analysis

10 December 2021 by Haseltine Lake Kempner

David Hammond of Haseltine Lake Kempner analyses EPO filings and proceedings data relating to foodstuffs, including plant-based meat and dairy substitutes

News & Analysis

Patents in India and access to medicines during COVID times

01 September 2021 by Manisha Singh and Pankaj Musyuni

Manisha Singh and Pankaj Musyuni of LexOrbis discuss how patent rights are impeding access to medicines and what can be done to minimise the damage caused by COVID-19

News & Analysis

A closer look at Malaysia’s recent IP developments

09 August 2021 by Jason Cheah and Chew Qi-Guang

Jason Cheah and Chew Qi-Guang of Henry Goh & Co discuss the latest updates in Malaysian IP law and the proposed legislative changes

News & Analysis

Year in Review: notable 2020 patent cases in the Netherlands

02 August 2021 by Bird & Bird

Bird & Bird’s IP lawyers summarise some of the notable patent decisions in the Netherlands last year

News & Analysis

China’s drug-patent linkage system has landed

16 June 2021 by Lili Wu, Ying Li, Yulian Hu and Linlin Zhang

Lili Wu, Ying Li, Yulian Hu and Linlin Zhang of Han Kun Law Offices explain how China’s drug-patent linkage system promotes and encourages innovation and development of the pharmaceutical industry

News & Analysis

Is a licence agreement principally a covenant not to sue?

13 July 2020 by Cystal Chen, Jesse Peng and Kevin Feng

Cystal Chen, Jesse Peng and Kevin Feng of Tsai Lee & Chen analyse a dispute in which the plaintiff argued that a licence agreement is a covenant not to sue and that use of the licensed patents is irrelevant

News & Analysis